At age 2, gene therapy enters a growth phase.
Thompson
L
L
D000163:Acquired Immunodeficiency Syndrome / Q000628:therapy; D000243:Adenosine Deaminase / Q000172:deficiency; D004279:DNA, Viral / Q000235:genetics; D015316:Genetic Therapy / Q000639:trends*; D005822:Genetic Vectors; D006678:HIV / Q000235:genetics; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000628:therapy; D009316:National Institutes of Health (U.S.); D009369:Neoplasms / Q000628:therapy; D012190:Retroviridae / Q000235:genetics; D014162:Transfection; D014481:United States
D004279:DNA, Viral; D000243:Adenosine Deaminase